Health care stocks were decreasing Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding 0.2%.
The iShares Biotechnology ETF (IBB) fell 1.8%.
In corporate news, Walgreens Boots Alliance (WBA) reported Friday better-than-expected fiscal Q1 results buoyed by sales growth across its divisions, and the drugstore chain reiterated its full-year earnings outlook amid a challenging US retail environment. Its shares jumped past 28%.
TransMedics (TMDX) shares were down 6.4% following a short seller report by Scorpion Capital, which called the company an "organ trafficking scheme masquerading as a medical device company."
Royalty Pharma (RPRX) shares jumped nearly 13% after the company said it would buy its external manager RP Management for about $1.1 billion, including 24.5 million in shares that will vest over five to nine years, about $100 million in cash, and the assumption of $380 million of debt.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.